231. Deputy Luke 'Ming' Flanagan asked the Minister for Health the reason this country needs to put cannabis based medicines of which Sativex is one such brand through clinical trials when the products are already clinically approved by the Mutual Recognition Procedure which operates throughout Europe; if the Irish Medicines Board has already approved such medicines; and if he will make a statement on the matter. [46550/12]

Summary

231. Deputy Luke 'Ming' Flanagan asked the Minister for Health the reason this country needs to put cannabis based medicines of which Sativex is one such brand through clinical trials when the products are already clinically approved by the Mutual Recognition Procedure which operates throughout Europe; if the Irish Medicines Board has already approved such medicines; and if he will make a statement on the matter. [46550/12]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Licensing

  xml · EN · 24 October 2012

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.